← All Sponsors
SPONSOR

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: AKI - Acute Kidney InjuryBiomarkersTransition to CKDCKD
NCT05713851 Phase 2, Phase 3
Recruiting

Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study

AKI - Acute Kidney Injury
Mexico View Trial →